NEW YORK (GenomeWeb) – Molecular diagnostics, including PCR-based multiplex panels, are transforming the clinical lab workflow. However, as more firms develop and attempt to commercialize PCR panels, a debate has developed over their appropriate design and use.

This debate was highlighted in an article recently published in the Journal of Clinical Microbiology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.